PRFX 0.98 (-10.91%)
IL0011651580Drug ManufacturersDrug Manufacturers - Specialty & Generic

PainReform (PRFX) Competitor Comparison

We are evaluating the key criteria listed to compare PainReform (PRFX) against its competitors in the Drug Manufacturers - Specialty & Generic industry.

Linearity 3 years - PRFX ranking 0 / 55

These are the competitors of PainReform in the industry Drug Manufacturers - Specialty & Generic ranked by linearity 3 years
1. Supernus Pharmaceuticals SUPN
44.17
2. Amneal Pharmaceuticals AMRX
22.21
3. Zoetis ZTS
21.59
4. Evolus EOLS
16.32
5. ProPhase Labs PRPH
11.81
6. Kolinpharma KIP.MI
11.59
7. Kamada KMDA
11.29
8. Ironwood Pharmaceuticals IRWD
9.36
9. Regencell Bioscience Holdings RGC
7.87
10. Perrigo PRGO
7.65
11. Alvotech ALVO
7
12. Teva Pharmaceutical Industries TEVA
6.45
13. Vifor Pharma G2AB.F
6.24
14. Cumberland Pharmaceuticals CPIX
4.57
15. Harrow Health HROW
4.1
16. Phibro Animal Health PAHC
4.08
17. Catalent CTLT
3.97
18. Pacira BioSciences PCRX
3.7
19. Taro Pharmaceutical Industries TARO
3.6
20. Elanco Animal Health ELAN
3.54
21. Linc LNC
3.46
22. Green Thumb Industries R9U2.F
3.21
23. Zynerba Pharmaceuticals ZYNE
3
24. OptiNose OPTN
2.93
25. PetIQ PETQ
2.89
26. Procaps Group PROC
2.81
27. Collegium Pharmaceutical COLL
2.67
28. Eagle Pharmaceuticals EGRX
2.63
29. Alimera Sciences ALIM
2.52
30. Embecta EMBC
2.5
31. Curaleaf Holdings CURLF
2.47
32. Societal CDMO SCTL
2.41
33. Bausch Health Companies BHC
2.38
34. Journey Medical DERM
2.28
35. Cronos Group CRON
2.21
36. Amphastar Pharmaceuticals AMPH
2.18
37. Theratechnologies THTX
2.16
38. SCYNEXIS SCYX
2.14
39. Clever Leaves Holdings CLVR
2.09
40. Relmada Therapeutics RLMD
1.98
41. Jupiter Wellness JUPW
1.84
42. Ascend Wellness Holdings AAWH
1.81
43. Flora Growth FLGC
1.8
44. Alpha Teknova TKNO
1.78
45. Ayr Wellness 3KJB.F
1.76
46. Tilray Brands TLRY
1.74
47. Biofrontera BFRI
1.73
48. Organogenesis Holdings ORGO
1.71
49. Emergent BioSolutions EBS
1.7
50. Universe Pharmaceuticals UPC
1.66
51. ANI Pharmaceuticals ANIP
1.63
52. Neoleukin Therapeutics NLTX
1.57
53. Avadel Pharmaceuticals AVDL
1.54
54. Solid Biosciences SLDB
1.52
55. MedAvail Holdings MDVL
1.31

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.